Recent posts

How Analytical Technologies Support the Development of Biosimilar Drugs

By January 12, 2017

Advancements in High-Resolution Analytics for the Characterization of Innovator and Biosimilar Therapeutics As the pharmaceutical industry continues to evolve its focus from small-molecule drugs to balanced product portfolios that include protein therapeutics, analytical chemists are… Read more >

Categories: Pharmaceutical
Tags: , , , , , , , , , ,

Oligonucleotide Therapeutics on the Rise… Again

By July 7, 2016

Oligonucleotide drug development has seen its share of ups and downs over the past 20 years – but why? The promise of antisense oligonucleotides (ASOs) and later small interfering oligonucleotides (siRNAs) as therapeutics that can… Read more >

Categories: Pharmaceutical
Tags: , ,

Tandem Quad Mass Spectrometry: The Foundation of Product Safety, Efficacy, and Decision-making

By May 17, 2016

There is a rightfully high expectation from consumers that the amounts of compounds and ingredients that producers report in their goods are accurate down to trace levels.  Whether personally or professionally, we all rely on… Read more >

Categories: Technologies
Tags: , , , , , ,

Out with the old, in with the new…

By May 3, 2016

We’re all familiar with the adage, “Out with the old, in with the new,” but we probably tend to think of it as it applies to clothes for donation or past relationships, and maybe not… Read more >

Categories: Pharmaceutical
Tags: , , ,

Mass detection and mAb QC: How a cost-effective and robust peptide mapping method confirms CDR peptides – and can be validated

By March 15, 2016

The quality issues of biopharmaceutical therapeutics are definitely different from chemical drugs because of the increased complexity of manufacturing processes and complexity of the biologic molecules themselves. There is an increasing need for detailed product… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , , , ,

A View of the Biopharmaceutical Industry in Asia — an Interview with Ken Fountain

By March 14, 2016

Ken Fountain, Director of Biopharmaceutical Business Development at Waters, recently returned from an insightful trip to Asia where he visited Waters customers in South Korea and attended the China Biopharma Executive Summit in Shanghai, in… Read more >

Categories: Pharmaceutical
Tags: , , ,

Three Reasons for Biopharmaceutical Labs to Add Mass Detection to Routine Analyses

By March 9, 2016

As regulators focus in on the critical quality attributes of biotherapeutics, what can biopharmaceutical labs in late development or QC do to increase confidence in their bioseparations – other than to run more assays?

Categories: Pharmaceutical, Technologies
Tags: , , , , , , , , , , , , , , , , , , , ,

When Consumables Kits are Greater Than the Sum of their Parts

By March 7, 2016

ProteinWorks and GlycoWorks kits address more than sample prep challenges One of the most challenging parts of an LC-MS workflow happens before analytical chemists even turn to their instrument: Sample preparation. Get it right, and… Read more >

Categories: Pharmaceutical, Technologies
Tags: , ,

The Answer to Fast, Sensitive, and Simple Released N-Glycan Profiling and Characterization

By March 9, 2015

How quickly can you go from glycosylated protein to glycan fragment confirmation?   Now, analyzing released N-glycans takes about as much time as it does for Tom Brady and the New England Patriots to erase… Read more >

Categories: Pharmaceutical, Technologies
Tags: ,

Waters and Ferring Collaborate to Host Peptide Bioanalysis Forum

By February 12, 2015

Close to sixty scientists from across Western Europe gathered for the Peptide Bioanalysis Forum held on-site at Ferring Pharmaceuticals A/S in Copenhagen on February 3-4, 2015. A collaborative effort between Ferring Pharmaceuticals and Waters Corporation,… Read more >

Categories: Pharmaceutical
Tags: , , ,